Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder

• Status: Completed
• Trial end date: 2007-04-01

Summary

The purpose of this study is to determine whether treatment with Quetiapine Fumarate (SEROQUEL) in conjunction with mood stabilizers (Lithium or Divalproex) for 12 weeks helps patients who have Bipolar I Disorder with Alcohol Dependence

• Phase: Phase 3

Details

• Lead Sponsor: AstraZeneca
• Treatments: Ethanol; Lithium Carbonate; Quetiapine Fumarate; Valproic Acid